\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ neuro\\:\\ headache\\,\\ ataxia\\ \\ \ \(0\)\
\-\ labs\\:\\ igf\\-1\\:36\\,\\ cortisol\\:\\ 16\\ \\ t4\\(free\\)\\:\\ 0\\.95\\ \\ tsh\\:\\ 3\\.15\ \(0\)\
\-\ pt\\ underwent\\ craniotomy\\ and\\ resection\\ of\\ the\\ craniopharyngioma\\.\\ \\ surgery\\ was\\ successful\\ in\\ resection\\ and\\ margins\\ were\\ clear\\ of\\ tumor\\.\\ he\\ was\\ discharged\\ and\\ is\\ followed\\ by\\ endocrinology\\ to\\ monitor\\ for\\ panhypopituitarism\\.\ \(0\)\
\-\ \\â\\€\\¢\\ non\\-contrast\\ ct\\:\\ a\\ small\\ intrasellar\\ \\+\\ suprasellar\\ mass\\ is\\ demonstrated\\ with\\ peripheral\\ rim\\ calcifications\\.\\ \\ it\\ measures\\ 2\\.5\\ cm\\ vertically\\,\\ 1\\.7\\ cm\\ transverse\\,\\ 1\\.6\\ cm\\ ap\\.\\ \\ mild\\ elevation\\ of\\ optic\\ chiasm\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\ w\\/\\ and\\ w\\/out\\ iv\\ contrast\\:\\ sellar\\ and\\ suprasellar\\ cystic\\ mass\\,\\ peripheral\\ calcifications\\ contents\\ are\\ slightly\\ hyperintense\\ to\\ gray\\ matter\\ on\\ precontrast\\ t1\\ imaging\\.\\ \\ shows\\ peripheral\\ enhancement\\.\\ \\ optic\\ nerves\\ splayed\\ by\\ the\\ mass\\ and\\ chiasm\\ is\\ elevated\\.\\ \\ mass\\ fills\\ the\\ sella\\,\\ and\\ the\\ normal\\ pituitary\\ is\\ not\\ well\\ seen\\.\\ \\ no\\ hydrocephalus\\ and\\ no\\ evidence\\ of\\ metastatic\\ disease\\.\ \(0\)\
\-\ adamantinomatous\\ craniopharyngioma\\ \\(who\\ grade\\ i\\)\ \(0\)\
\-\ brain\\ tumor\\ \\(craniopharyngioma\\)\\,\\ pituitary\\ adenoma\\,\\ granuloma\\,\\ rathke\\â\\€\\™s\\ cleft\\ cyst\\,\\ aneurysm\\,\\ pituitary\\ apoplexy\\,\\ metastatic\\ carcinoma\ \(0\)\
\-\ 23\\ month\\ old\\ boy\\ presents\\ with\\ headaches\\ of\\ 3\\ weeks\\ duration\\.\\ \\ the\\ episodes\\ are\\ accompanied\\ by\\ stumbling\\ and\\ vomiting\\,\\ 1\\-3\\ times\\ per\\ day\\.\\ \\ he\\ also\\ has\\ a\\ decreased\\ appetite\\ and\\ fluctuating\\ weight\\.\\ \\ birth\\ history\\ was\\ unremarkable\\,\\ vaginal\\ delivery\\ at\\ 38\\ wks\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.24828551374395932\ \(0\)\
\-\ pituitary\\:\\ 0\\.23703204266187128\ \(0\)\
\-\ peripheral\\:\\ 0\\.18375422057976146\ \(0\)\
\-\ chiasm\\:\\ 0\\.181826923220904\ \(0\)\
\-\ and\\:\\ 0\\.17699834151226695\ \(0\)\
\-\ suprasellar\\:\\ 0\\.16806309184050378\ \(0\)\
\-\ cm\\:\\ 0\\.14758022464204856\ \(0\)\
\-\ optic\\:\\ 0\\.14746822808694887\ \(0\)\
\-\ stumbling\\:\\ 0\\.13089469989636127\ \(0\)\
\-\ mass\\:\\ 0\\.1308737423664643\ \(0\)\
\-\ panhypopituitarism\\:\\ 0\\.1265748854014049\ \(0\)\
\-\ splayed\\:\\ 0\\.1265748854014049\ \(0\)\
\-\ calcifications\\:\\ 0\\.12502798649415828\ \(0\)\
\-\ fluctuating\\:\\ 0\\.12322417696410831\ \(0\)\
\-\ adamantinomatous\\:\\ 0\\.12048644882877745\ \(0\)\
\-\ precontrast\\:\\ 0\\.11817173267197982\ \(0\)\
\-\ intrasellar\\:\\ 0\\.11281592589652449\ \(0\)\
\-\ cortisol\\:\\ 0\\.11007819776119362\ \(0\)\
\-\ resection\\:\\ 0\\.10981365754507426\ \(0\)\
\-\ by\\:\\ 0\\.10912395051692465\ \(0\)\
\-\ sellar\\:\\ 0\\.10672748932389702\ \(0\)\
\-\ endocrinology\\:\\ 0\\.10575838326623728\ \(0\)\
\-\ wks\\:\\ 0\\.10575838326623728\ \(0\)\
\-\ apoplexy\\:\\ 0\\.10398976118856615\ \(0\)\
\-\ he\\:\\ 0\\.10144509049343112\ \(0\)\
\-\ vertically\\:\\ 0\\.10030901897816061\ \(0\)\
\-\ fills\\:\\ 0\\.0963192382563132\ \(0\)\
\-\ metastatic\\:\\ 0\\.09395643613990526\ \(0\)\
\-\ is\\:\\ 0\\.09383028357317733\ \(0\)\
\-\ rathke\\:\\ 0\\.09358151012098234\ \(0\)\
\-\ accompanied\\:\\ 0\\.09358151012098234\ \(0\)\
\-\ craniotomy\\:\\ 0\\.09162864116487056\ \(0\)\
\-\ appetite\\:\\ 0\\.08990076791057679\ \(0\)\
\-\ tumor\\:\\ 0\\.08960647201139095\ \(0\)\
\-\ was\\:\\ 0\\.08955624847791359\ \(0\)\
\-\ sella\\:\\ 0\\.08864871532406024\ \(0\)\
\-\ monitor\\:\\ 0\\.08749307354835487\ \(0\)\
\-\ t4\\:\\ 0\\.08591098718872937\ \(0\)\
\-\ contents\\:\\ 0\\.08566278431132444\ \(0\)\
\-\ the\\:\\ 0\\.08545771865012046\ \(0\)\
\-\ of\\:\\ 0\\.0838128338628881\ \(0\)\
\-\ contrast\\:\\ 0\\.08323733427966792\ \(0\)\
\-\ ataxia\\:\\ 0\\.08317325905339852\ \(0\)\
\-\ successful\\:\\ 0\\.08317325905339852\ \(0\)\
\-\ tsh\\:\\ 0\\.08276183791465311\ \(0\)\
\-\ duration\\:\\ 0\\.08256027875143276\ \(0\)\
\-\ vaginal\\:\\ 0\\.08256027875143276\ \(0\)\
\-\ delivery\\:\\ 0\\.08050521054286817\ \(0\)\
\-\ nerves\\:\\ 0\\.07999032814032832\ \(0\)\
\-\ neuro\\:\\ 0\\.07982255061610191\ \(0\)\
\-\ episodes\\:\\ 0\\.07824046425647642\ \(0\)\
\-\ elevation\\:\\ 0\\.07809105076302235\ \(0\)\
\-\ granuloma\\:\\ 0\\.07750783445930426\ \(0\)\
\-\ cleft\\:\\ 0\\.07736550228274612\ \(0\)\
\-\ times\\:\\ 0\\.07708482248077105\ \(0\)\
\-\ birth\\:\\ 0\\.07653872840164454\ \(0\)\
\-\ 38\\:\\ 0\\.07601179952256647\ \(0\)\
\-\ discharged\\:\\ 0\\.07351328753135447\ \(0\)\
\-\ gray\\:\\ 0\\.07329566151633181\ \(0\)\
\-\ margins\\:\\ 0\\.07308114455089833\ \(0\)\
\-\ per\\:\\ 0\\.07108936411356785\ \(0\)\
\-\ pe\\:\\ 0\\.07081213902970293\ \(0\)\
\-\ 23\\:\\ 0\\.07063012550178317\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.06992336294993899\ \(0\)\
\-\ measures\\:\\ 0\\.0698373115270513\ \(0\)\
\-\ adenoma\\:\\ 0\\.06828958658333442\ \(0\)\
\-\ rim\\:\\ 0\\.06821238367702542\ \(0\)\
\-\ hyperintense\\:\\ 0\\.06813557567221942\ \(0\)\
\-\ slightly\\:\\ 0\\.06681625551069795\ \(0\)\
\-\ 16\\:\\ 0\\.06674625103798774\ \(0\)\
\-\ free\\:\\ 0\\.06667657141318722\ \(0\)\
\-\ transverse\\:\\ 0\\.06599700150231816\ \(0\)\
\-\ matter\\:\\ 0\\.06522014212324297\ \(0\)\
\-\ aneurysm\\:\\ 0\\.06522014212324297\ \(0\)\
\-\ are\\:\\ 0\\.06500537145552288\ \(0\)\
\-\ headaches\\:\\ 0\\.06389256918206909\ \(0\)\
\-\ vomiting\\:\\ 0\\.06338158078452998\ \(0\)\
\-\ clear\\:\\ 0\\.062098300757942385\ \(0\)\
\-\ pt\\:\\ 0\\.06164400261330472\ \(0\)\
\-\ grade\\:\\ 0\\.06159436312281106\ \(0\)\
\-\ ap\\:\\ 0\\.061495573738860186\ \(0\)\
\-\ iv\\:\\ 0\\.06120304632794384\ \(0\)\
\-\ weight\\:\\ 0\\.05973242294279432\ \(0\)\
\-\ labs\\:\\ 0\\.0593434993607386\ \(0\)\
\-\ headache\\:\\ 0\\.05904781744305311\ \(0\)\
\-\ underwent\\:\\ 0\\.05900604848093427\ \(0\)\
\-\ boy\\:\\ 0\\.05859462734218886\ \(0\)\
\-\ elevated\\:\\ 0\\.05839306817896851\ \(0\)\
\-\ followed\\:\\ 0\\.057842684446277756\ \(0\)\
\-\ unremarkable\\:\\ 0\\.057423962121308784\ \(0\)\
\-\ no\\:\\ 0\\.055708934772715005\ \(0\)\
\-\ day\\:\\ 0\\.05456161972557519\ \(0\)\
\-\ brain\\:\\ 0\\.053397936674736225\ \(0\)\
\-\ t1\\:\\ 0\\.05336925293688417\ \(0\)\
\-\ decreased\\:\\ 0\\.0530572960058175\ \(0\)\
\-\ demonstrated\\:\\ 0\\.052642082486145374\ \(0\)\
\-\ month\\:\\ 0\\.052105742179495325\ \(0\)\
\-\ cystic\\:\\ 0\\.051587900097789574\ \(0\)\
\-\ weeks\\:\\ 0\\.05133552554868131\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0512357515457209\ \(0\)\
\-\ shows\\:\\ 0\\.050272861978400224\ \(0\)\
\-\ cyst\\:\\ 0\\.04941198459446987\ \(0\)\
\-\ enhancement\\:\\ 0\\.04930229869989414\ \(0\)\
\-\ evidence\\:\\ 0\\.048618667371122117\ \(0\)\
\-\ mild\\:\\ 0\\.048556144315352996\ \(0\)\
\-\ who\\:\\ 0\\.048452514282238346\ \(0\)\
\-\ surgery\\:\\ 0\\.046052471740503816\ \(0\)\
\-\ imaging\\:\\ 0\\.0450153059277312\ \(0\)\
\-\ small\\:\\ 0\\.04418442540577275\ \(0\)\
\-\ were\\:\\ 0\\.04415336865799137\ \(0\)\
\-\ mri\\:\\ 0\\.04396836509975518\ \(0\)\
\-\ it\\:\\ 0\\.04384628367771546\ \(0\)\
\-\ to\\:\\ 0\\.04282783391855961\ \(0\)\
\-\ well\\:\\ 0\\.04147522249345674\ \(0\)\
\-\ presents\\:\\ 0\\.04120512135556686\ \(0\)\
\-\ seen\\:\\ 0\\.040326311732553924\ \(0\)\
\-\ also\\:\\ 0\\.040290287887528524\ \(0\)\
\-\ has\\:\\ 0\\.0391253206867444\ \(0\)\
\-\ disease\\:\\ 0\\.0359554889265053\ \(0\)\
\-\ normal\\:\\ 0\\.03497290962236109\ \(0\)\
\-\ not\\:\\ 0\\.03381508581940762\ \(0\)\
\-\ with\\:\\ 0\\.03354516480445987\ \(0\)\
\-\ history\\:\\ 0\\.032725680914892724\ \(0\)\
\-\ ct\\:\\ 0\\.03261017317456006\ \(0\)\
\-\ at\\:\\ 0\\.032353484322247425\ \(0\)\
\-\ for\\:\\ 0\\.025961779528561362\ \(0\)\
\-\ on\\:\\ 0\\.02586968520615598\ \(0\)\
\-\ old\\:\\ 0\\.025350831665018964\ \(0\)\
\-\ in\\:\\ 0\\.021308517704355975\ \(0\)\
